Clostridium difficile ribotype does not predict severe infection.
about
Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic reviewLaboratory diagnosis of bacterial gastroenteritisClinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 StrainsClostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities.Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortalityMicrobiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotypingDoes Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection?The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates.Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance.Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolatesIntestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections.International Clostridium difficile animal strain collection and large diversity of animal associated strainsEpidemiology of Clostridium difficile infectionThe role of the humoral immune response to Clostridium difficile toxins A and B in susceptibility to C. difficile infection: a case-control study.Procalcitonin levels associate with severity of Clostridium difficile infectionClostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB.Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review.Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficileThe systemic inflammatory response to Clostridium difficile infectionEvaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology.Clostridium difficile PCR Ribotype 018, a Successful Epidemic GenotypeVariation in germination of Clostridium difficile clinical isolates correlates to disease severity.Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011.Clostridium difficile ribotypes in Austria: a multicenter, hospital-based surveyComparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal diseaseClostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortalityGrowth Patterns of Clostridium difficile - Correlations with Strains, Binary Toxin and Disease Severity: A Prospective Cohort Study.Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 StrainsFactors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective CohortSurface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune responseNAP1 strain type predicts outcomes from Clostridium difficile infection.In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.Fulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin.Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.Clostridium difficile ribotype diversity at six health care institutions in the United StatesDiagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.A clinical and epidemiological review of non-toxigenic Clostridium difficile.
P2860
Q27021390-4AC8BC9C-1CF0-4BBA-9F5E-A5359D5AF737Q27027754-C2B309F4-2533-4030-9C5D-2F83CA7EC0ADQ28354123-03C4C46C-A361-4B85-AED8-E0DDCF3277F7Q30365997-83CCF8F5-3AB2-482D-9EF4-AD81716F8220Q30413111-F34EEC57-2C02-4568-9946-CC8307BB0C2DQ30815476-D3315ADE-1367-453D-8291-110C78FD8FE4Q33594512-713E2FC6-162E-49E2-AE79-BBAC60B87E71Q33629080-A31715A2-7A32-4B2F-804B-0F0A9A7B66B5Q33684178-B8D42030-A78A-45AB-A415-3D493DC63C1EQ33728296-C0CEE8B9-0D8D-442B-B34A-EE4AB69B32AFQ33899721-4894410A-6B44-4DD3-8DFC-DFE7F43BB232Q33903892-BD7573C5-91D5-447F-98D0-4CEAFA23F9DCQ33909227-3248480C-EFBC-4AFB-A50E-24609EAA289EQ34027474-0F3CC63C-6325-4808-92DC-954E4C72E586Q34074371-65D55373-E50B-4D35-893C-D641F93F5302Q34625689-C1FDAE74-9500-47F3-B1A3-5E881FB7D55FQ34916871-C81CC97D-915B-4371-8972-8CC8126CED76Q35044119-5BCAC7B5-AA74-4D0B-A64E-8D0C9DF1F590Q35087507-5AFF8EB2-6797-4FE2-B860-442E865E1F01Q35095564-66FC6AF7-84DD-438A-B94F-A39EFDB03C7EQ35124315-AA6C2845-6E8B-4D3F-8F2B-8C59CE28F174Q35193241-83C9105C-DAA8-4714-A33F-C7AD3CC13B59Q35652292-79284F53-195D-4AA9-9275-C791F4469F19Q35742764-41456468-8D89-41D4-9710-17C1A9056B03Q35898112-174E0DD2-D15C-4873-B2DB-AC956F3C3042Q35952584-39802806-418B-4593-8974-82CEF7B6605DQ35955254-68FCE186-A8BE-4784-B8DF-C0F49AABE5D6Q36049005-08E4F80F-3CDA-4C2E-89E1-9FFC498563DBQ36123790-C01ABB84-D663-4E58-9431-24797C98DD03Q36261170-DA44BFC9-EF4E-4723-907E-C06E20197E03Q36311457-71F39C72-175F-49A5-A7D1-180E48F1C5A0Q36320846-F6FC397A-CBCD-44EA-B452-C3D3631EAE31Q36420815-2CBA265B-ED6D-45B6-8DD5-8A3ECDD3A08CQ36455915-7520E189-2A39-473B-A2C1-FC5B896CDDFFQ36680914-1164BE8A-9E3C-42D7-B8EF-29D499AE41C7Q36811255-1BC7DAF8-EE6C-4433-B73A-141E02F6F4B8Q36999988-84D9825D-3154-43D0-8D89-E3C9E88EAD06Q37026536-E10A0968-E0CE-4022-BD7F-8D2618D736BAQ37035829-0F220CA4-2B0B-4FA7-A83D-423D34795571Q37060179-6EAAC546-D013-469D-8D13-8A9A722A4CAD
P2860
Clostridium difficile ribotype does not predict severe infection.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Clostridium difficile ribotype does not predict severe infection.
@ast
Clostridium difficile ribotype does not predict severe infection.
@en
type
label
Clostridium difficile ribotype does not predict severe infection.
@ast
Clostridium difficile ribotype does not predict severe infection.
@en
prefLabel
Clostridium difficile ribotype does not predict severe infection.
@ast
Clostridium difficile ribotype does not predict severe infection.
@en
P2093
P2860
P356
P1476
Clostridium difficile ribotype does not predict severe infection.
@en
P2093
Andrzej T Galecki
Cathrin Ring
Dejan Micic
Duane W Newton
Eugene S Lo
Eugene W Liu
Itishree Trivedi
Laraine Washer
Luay M Almassalha
Mary A M Rogers
P2860
P304
P356
10.1093/CID/CIS786
P407
P577
2012-09-12T00:00:00Z